Topics

Prothena Corporation plc: Prothena Reports Fourth Quarter and Full Year 2019 Financial Results, and Provides Financial Guidance and R&D Update

16:17 EST 12 Feb 2020 | FinanzNachrichten

Net cash used in operating and investing activities was $14.6 million in the fourth quarter and $53.5 million for the full year 2019; quarter-end cash and restricted cash position of $378.4 million...

Original Article: Prothena Corporation plc: Prothena Reports Fourth Quarter and Full Year 2019 Financial Results, and Provides Financial Guidance and R&D Update

NEXT ARTICLE

More From BioPortfolio on "Prothena Corporation plc: Prothena Reports Fourth Quarter and Full Year 2019 Financial Results, and Provides Financial Guidance and R&D Update"

Quick Search